FRACP questions Flashcards

1
Q

TIMI grading

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

hi flow oxygen in STEMI pts

A

NO unless hypoxic

Supplemental oxygen can have delterious effects in non-hypoxic patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Types of AMI

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PCI vs CABG in patient with ACS with left main artery disease only

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GRACE score in ACS

A

Calculates 6month and 3 year mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TIMACS study

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Re vascuarisatin in non culprit lesions on patients during PCI for STEMI?

A

YES!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Radial vs femoral access for coronary angiogram

A

Radial access related to signifcantly lower vascular complications reduction in all-cause mortality,

Contrast induced nephropathy not yet studied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Benefit of early intervention in high risk patients post thrombolysis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dabigatran

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Triple therapy in AF and ACS

A

Triple therapy, OAC, aspriin and clopridogrel for 6 months in patient post DES if low risk for bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which drug comibnation post-PCI is the safest in terms of future bleeding risk?

A

Low dose rivaroxaban plus DAPT

HOWEVER - these dosing regimens have not been formally investigated and are not FDA approved for AF or ACS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Evolocumab

A

Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ezetimibe added to statin therapy after ACS

A

Yes!

IMPROVE -IT!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute renal failure after angiogram

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Complete heart block findings

A
17
Q

JVP waveform

A
18
Q

Salt intake beneficial to reducing cardiovascular events

A

3 to 6g/day

19
Q

Findings in MS

A
20
Q

Mitral regurgitation on doppler

A
21
Q

MS severity and intervention

A
22
Q

Clopidogrel vs ticagreolor

PLATO study

A
23
Q

Aortic stenosis on doppler

A
24
Q

Indication for surgery in Mitral regurgitation

A
25
Q

Contraindications to percutaneous mitral balloon valvotomy for mod to severe stenosis

A
26
Q

MURMURS

A
27
Q

Most common artery involved in occlusion in ascending aortic dissection?

A

RIGHT coronary artery